245 related articles for article (PubMed ID: 3782075)
1. Role of ternary complexes, in which heparin binds both antithrombin and proteinase, in the acceleration of the reactions between antithrombin and thrombin or factor Xa.
Danielsson A; Raub E; Lindahl U; Björk I
J Biol Chem; 1986 Nov; 261(33):15467-73. PubMed ID: 3782075
[TBL] [Abstract][Full Text] [Related]
2. Mechanism of acceleration of antithrombin-proteinase reactions by low affinity heparin. Role of the antithrombin binding pentasaccharide in heparin rate enhancement.
Streusand VJ; Björk I; Gettins PG; Petitou M; Olson ST
J Biol Chem; 1995 Apr; 270(16):9043-51. PubMed ID: 7721817
[TBL] [Abstract][Full Text] [Related]
3. Role of the antithrombin-binding pentasaccharide in heparin acceleration of antithrombin-proteinase reactions. Resolution of the antithrombin conformational change contribution to heparin rate enhancement.
Olson ST; Björk I; Sheffer R; Craig PA; Shore JD; Choay J
J Biol Chem; 1992 Jun; 267(18):12528-38. PubMed ID: 1618758
[TBL] [Abstract][Full Text] [Related]
4. Anticoagulant activities of heparin oligosaccharides and their neutralization by platelet factor 4.
Lane DA; Denton J; Flynn AM; Thunberg L; Lindahl U
Biochem J; 1984 Mar; 218(3):725-32. PubMed ID: 6721831
[TBL] [Abstract][Full Text] [Related]
5. Effects of heparin fractions of different affinities to antithrombin III and thrombin on the inactivation of thrombin and factor Xa by antithrombin III.
Cerskus AL; Birchall KJ; Ofosu FA; Hirsh J; Blajchman MA
Can J Biochem Cell Biol; 1984 Oct; 62(10):975-83. PubMed ID: 6509363
[TBL] [Abstract][Full Text] [Related]
6. Multiple functional domains of the heparin molecule.
Oosta GM; Gardner WT; Beeler DL; Rosenberg RD
Proc Natl Acad Sci U S A; 1981 Feb; 78(2):829-33. PubMed ID: 6940150
[TBL] [Abstract][Full Text] [Related]
7. Kinetic analysis of various heparin fractions and heparin substitutes in the thrombin inhibition reaction.
Pletcher CH; Cunningham M; Nelsestuen GL
Biochim Biophys Acta; 1985 Jan; 838(1):106-13. PubMed ID: 2578296
[TBL] [Abstract][Full Text] [Related]
8. Calcium enhances heparin catalysis of the antithrombin-factor Xa reaction by promoting the assembly of an intermediate heparin-antithrombin-factor Xa bridging complex. Demonstration by rapid kinetics studies.
Rezaie AR; Olson ST
Biochemistry; 2000 Oct; 39(39):12083-90. PubMed ID: 11009624
[TBL] [Abstract][Full Text] [Related]
9. Antithrombin binding of low molecular weight heparins and inhibition of factor Xa.
Lin P; Sinha U; Betz A
Biochim Biophys Acta; 2001 Apr; 1526(1):105-13. PubMed ID: 11287128
[TBL] [Abstract][Full Text] [Related]
10. Isolation of a pure octadecasaccharide with antithrombin activity from an ultra-low-molecular-weight heparin.
Mourier PA; Guichard OY; Herman F; Viskov C
Anal Biochem; 2014 May; 453():7-15. PubMed ID: 24561026
[TBL] [Abstract][Full Text] [Related]
11. The active site of antithrombin. Release of the same proteolytically cleaved form of the inhibitor from complexes with factor IXa, factor Xa, and thrombin.
Björk I; Jackson CM; Jörnvall H; Lavine KK; Nordling K; Salsgiver WJ
J Biol Chem; 1982 Mar; 257(5):2406-11. PubMed ID: 6977539
[TBL] [Abstract][Full Text] [Related]
12. Heparin enhances the specificity of antithrombin for thrombin and factor Xa independent of the reactive center loop sequence. Evidence for an exosite determinant of factor Xa specificity in heparin-activated antithrombin.
Chuang YJ; Swanson R; Raja SM; Olson ST
J Biol Chem; 2001 May; 276(18):14961-71. PubMed ID: 11278930
[TBL] [Abstract][Full Text] [Related]
13. Lysine-heparin interactions in antithrombin. Properties of K125M and K290M,K294M,K297M variants.
Fan B; Turko IV; Gettins PG
Biochemistry; 1994 Nov; 33(47):14156-61. PubMed ID: 7947827
[TBL] [Abstract][Full Text] [Related]
14. The antithrombin P1 residue is important for target proteinase specificity but not for heparin activation of the serpin. Characterization of P1 antithrombin variants with altered proteinase specificity but normal heparin activation.
Chuang YJ; Swanson R; Raja SM; Bock SC; Olson ST
Biochemistry; 2001 Jun; 40(22):6670-9. PubMed ID: 11380262
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms responsible for catalysis of the inhibition of factor Xa or thrombin by antithrombin using a covalent antithrombin-heparin complex.
Paredes N; Wang A; Berry LR; Smith LJ; Stafford AR; Weitz JI; Chan AK
J Biol Chem; 2003 Jun; 278(26):23398-409. PubMed ID: 12695507
[TBL] [Abstract][Full Text] [Related]
16. Binding of platelet factor 4 to heparin oligosaccharides.
Denton J; Lane DA; Thunberg L; Slater AM; Lindahl U
Biochem J; 1983 Feb; 209(2):455-60. PubMed ID: 6847629
[TBL] [Abstract][Full Text] [Related]
17. Accelerating ability of synthetic oligosaccharides on antithrombin inhibition of proteinases of the clotting and fibrinolytic systems. Comparison with heparin and low-molecular-weight heparin.
Olson ST; Swanson R; Raub-Segall E; Bedsted T; Sadri M; Petitou M; Hérault JP; Herbert JM; Björk I
Thromb Haemost; 2004 Nov; 92(5):929-39. PubMed ID: 15543318
[TBL] [Abstract][Full Text] [Related]
18. Role of heparin and heparinlike molecules in thrombosis and atherosclerosis.
Rosenberg RD
Fed Proc; 1985 Feb; 44(2):404-9. PubMed ID: 3155697
[TBL] [Abstract][Full Text] [Related]
19. Conversion of antithrombin from an inhibitor of thrombin to a substrate with reduced heparin affinity and enhanced conformational stability by binding of a tetradecapeptide corresponding to the P1 to P14 region of the putative reactive bond loop of the inhibitor.
Björk I; Ylinenjärvi K; Olson ST; Bock PE
J Biol Chem; 1992 Jan; 267(3):1976-82. PubMed ID: 1730729
[TBL] [Abstract][Full Text] [Related]
20. Decreased affinity of recombinant antithrombin for heparin due to increased glycosylation.
Björk I; Ylinenjärvi K; Olson ST; Hermentin P; Conradt HS; Zettlmeissl G
Biochem J; 1992 Sep; 286 ( Pt 3)(Pt 3):793-800. PubMed ID: 1417738
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
